L’Oréal has rolled out a groundbreaking tabletop device that delivers personalized skin analysis in just five minutes at the CES 2025 event. The newly launched Cell BioPrint utilizes state-of-the-art proteomics to evaluate skin age, responsiveness, and forecast potential issues to support proactive skincare treatments.
Recognizing consumer demand for more effective and tailored skincare solutions, skin analysis is set to become a crucial tool for meeting these needs. It reduces uncertainty, lessens trial and error, and enhances confidence in choosing the right skincare products.
Barbara Lavernos, the Deputy CEO responsible for Research, Innovation, and Technology at L’Oréal Group, comments, “As a leader in beauty innovation, our focus is on merging tomorrow’s discoveries with our rich history in the beauty industry. Since skin plays a vital role in an individual’s wellbeing, we are excited to introduce Cell BioPrint. This exclusive microfluidic lab-on-a-chip technology is integrated with our century-spanning expertise in skin science, offering individuals profound insights into their skin through specific biomarkers and enabling them to proactively care for their skin’s beauty and longevity.”